Fig. 7
From: Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
(A) IHC staining for ATP2C1[Negative control with PBS(a) and expression levels of hSPCA1 in HHD(b,c,d)]. (B) IHC staining for p63[Negative control with PBS(a) and p63 protein in the nucleus of HHD patients(b,c,d)]. (C) IHC staining for NotchI in normal skin (a) and HHD (b,c,d). (D) IHC staining for HKII in normal skin(a) and HHD patients(b,c,d). (E). Quantification for IHC staining signals in A ~ D